Argentina-based agricultural technology company specializing in biological solutions for regenerative agriculture to expand into new markets, fueled by new capital infusion BUENOS AIRES, Argentina, ...
Turning microalgae into high-value fuels: biochar-based catalyst unlocks cleaner aromatic production
Researchers have developed a new strategy to transform microalgae into high-value fuel chemicals more efficiently and cleanly ...
Many medicines are twisted molecules with two mirror image versions, but the body uses only one. Inspired by photosynthetic bacteria, a team built a catalyst that guides chemical reactions toward the ...
Sen. Bernie Sanders, I-Vt., isn’t the only pharma critic shining a light on relatively unknown drugmaker Catalyst Pharmaceuticals. The watchdogs at Patients For Affordable Drugs blasted the company’s ...
The controversy over a pricey rare-disease drug has ensnared the industry trade group for biotech companies, which is being challenged by a patent advocate to disavow “price gouging.” In a letter to ...
Researchers at Osaka Metropolitan University have developed a new catalyst that efficiently converts a glycerol derivative into bio-based propylene, supporting the production of sustainable chemicals.
FinancialNewsMedia.com issues news updates for today's leading healthcare companies: Bio-Solutions Corp. (OTCQB: BISU), Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), MannKind Corporation ...
With its Duchenne muscular dystrophy (DMD) drug, vamorolone, under U.S. FDA review, Santhera Pharmaceutical AG has signed a $231 million-plus-royalties North America commercialization deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results